Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Flerie Invest: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Flerie Invest
Flerie Invest
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Flerie Invest.
KE
Karl Elmqvist
Analyst
TE
Thomas Eldered
Executive Chairman
TF
Ted Fjällman
Partner
Leadership Team
Key people at Flerie Invest.
Karl Elmqvist
Analyst
Thomas Eldered
Executive Chairman
Ted Fjällman
Partner
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Jan 8, 2026
KAHR medical
$32.0M Debt / Other Equity
Ted Fjällman
,
Cancer Focus Fund
,
Oriella
,
Peregrine Ventures
SPRIM Global Investments
Feb 9, 2023
Prokarium
$30.0M Other Equity
Thomas Eldered
—
Sep 9, 2022
AnaCardio
$14.1M Series A
Mark Quick
,
Industrifonden
—
Mar 25, 2022
Geneos Therapeutics
$17.0M Series A
Ted Fjällman
Global Bio Fund
, INOVIO Pharmaceuticals
,
Korea Investment Partners
, Sante Ventures
Feb 1, 2022
Microbiotica
$68.0M Series B
Carl-Johan Spak
, Tencent
ARCH Venture Partners
,
Cambridge Innovation Capital
,
HealthCap
,
Mubadala
, Judith Hartley MBE
,
Seventure Partners
Dec 16, 2021
Synerkine Pharma
$4.0M Series A Extension
Ted Fjällman
Thuja Capital
,
Utrecht Holdings
Aug 18, 2021
EpiEndo Pharmaceuticals
$23.5M Series A
Carl-Johan Spak
, hilmar janusson
Ivar Gudjonsson
, European Innovation Council
Oct 1, 2020
Prokarium
$21.0M Series B
Korea Investment Partners
Future Fund
,
Riyadh Valley Company
Feb 25, 2020
KAHR medical
$18.0M Other Equity
Flerie Invest
,
Hadasit Bio-Holdings
,
Mirae Asset Venture Investment
,
Oriella
,
Pavilion Capital
—
Feb 1, 2018
Prokarium
$10.0M Series A
Khalid Al-Saleh
Korea Investment Partners
, Thomas Eldered
Dec 15, 2015
KAHR medical
$12.0M Series B
—
Korea Investment Partners
,
DSC Investment
,
Mirae Asset Venture Investment